Medical Device News Magazine

We are excited to announce that the Medical Affairs Summit Returns to Boston!

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Medical Affairs Summit is scheduled to take place on 12 – 13 October 2023 at the luxurious Encore Boston Harbor in Boston, MA, US. The event brings together key Clinical Trial Executives representing pharmaceutical industries in the Americas. The Summit offers a highly focused and interactive platform for attendees to address core concerns and find solutions tailored to their specific needs.

The Summit offers the opportunity for one-on-one business meetings, which allows sponsors to connect with key decision-makers in the industry. This can be instrumental in forging precious partnerships. This is an unparalleled opportunity for extensive networking among industry peers during one-on-one business meetings, event meals, cocktail receptions and leisure entertainment.

Previous attendees include:

  • Johnson & Johnson – Director, Global Program Leader – Oncology, Medical Affairs Operations
  • EMD Serono Inc.- Director, Strategic Planning and Performance Management
  • Janssen – Group Medical Director, Solid Tumors
  • Radius Health – Head: Medical Strategy & Integrated Evidence
  • Sobi Inc. – Director of Immunology, Medical Affairs
  • Vertex Pharmaceuticals – Medical Director

To enquire more information, please visit https://bit.ly/43CBrgl or directly contact Isidora Avraam at isidoraa@marcusevanscy.com.

#meMedAffairs

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”